(S)-3-Methyl-1-(2-piperidin-1-yl-phenyl)butylamine, 98.0%, 10g

Methyl 4-chloro-2-cyanobenzoate, 95.0%, 5g

5-Pentyldihydrofuran-2(3H)-one, 97.0%, 25g

TERT-BUTYL 2-IODO-4-METHOXYPHENYLCARBAMATE, 95.0%, 250mg

Ethyl 2-(3-nitrophenyl)acetate, 95.0%, 25g

Methyl 5-bromo-2-fluoro-3-methoxybenzoate, 98%, 1g

(7-chloro-2,3-dihydro-1,4-benzodioxin-6-yl)acetic acid, 95.0%, 1g

2-Cloroanilina 250mL, >=98%, per sintesi, 250mL, confezione in vetro

6-((BENZYLOXY)CARBONYL)-2-(TERT-BUTOXYCARBONYL)-2,6-DIAZASPIRO[3.4]OCTANE-8-CARBOXYLIC ACID, 95.0%, 2g

2-Ethyl-1-hexene>95.0%(GC)10mL

(R)-6-fluoro-3-(3-fluorophenyl)-2-(1-hydroxyethyl)-4H-chromen-4-one, 97%, 250mg

Tappi auricolari monouso X-fit, sfusi nella scatola di ricarica, 300 paia

1-tert-Butyl 2-ethyl 5-hydroxypiperidine-1,2-dicarboxylate, 95%, 5g